leadf
logo-loader
viewMGC Pharmaceuticals Ltd

MGC Pharma's new head of global sales has big ambitions and says they're 'ready to go'

Proactive's Andrew Scott speaks with MGC Pharmaceuticals Ltd's (ASX:MXC) (OTCMKT:MGCLF) recently appointed global chief sales officer Nicole Godresse. She'll lead the company’s global sales and marketing initiatives across Australia and New Zealand as well as build and implement a strong and focused pharma sales strategy by recruiting a highly experienced sales force around the world. Godresse adds that the company's progressing towards its target of achieving monthly cash flow breakeven by the end of 1H 2021.

Quick facts: MGC Pharmaceuticals Ltd

Price: 0.07 AUD

ASX:MXC
Market: ASX
Market Cap: $156.02 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of MGC Pharmaceuticals Ltd named herein, including the promotion by the Company of MGC Pharmaceuticals Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

MGC Pharmaceuticals get set for LSE debut as first medicinal cannabis...

MGC Pharmaceuticals Ltd's (ASX:MXC) (FRA:H5O) (LON:MXC) Co-founder and MD Roby Zomer joins Proactive London to explain why the company has chosen to list on the London Stock Exchange (LSE) on Tuesday, February 9.  This move will mean the firm will become the first medicinal cannabis...

1 month ago

2 min read